96 related articles for article (PubMed ID: 21120479)
21. Ligand for peroxisome proliferator-activated receptor gamma (troglitazone) has potent antitumor effect against human prostate cancer both in vitro and in vivo.
Kubota T; Koshizuka K; Williamson EA; Asou H; Said JW; Holden S; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3344-52. PubMed ID: 9699665
[TBL] [Abstract][Full Text] [Related]
22. Mitochondrial impairment by PPAR agonists and statins identified via immunocaptured OXPHOS complex activities and respiration.
Nadanaciva S; Dykens JA; Bernal A; Capaldi RA; Will Y
Toxicol Appl Pharmacol; 2007 Sep; 223(3):277-87. PubMed ID: 17658574
[TBL] [Abstract][Full Text] [Related]
23. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
Shim J; Kim BH; Kim YI; Kim KY; Hwangbo Y; Jang JY; Dong SH; Kim HJ; Chang YW; Chang R
Int J Oncol; 2010 Jan; 36(1):223-31. PubMed ID: 19956851
[TBL] [Abstract][Full Text] [Related]
24. Cytotoxic effects of a new antitumor antibiotic, FK973, in malignant glioma.
Moriuchi S; Shimizu K; Yamada M; Mabuchi E; Tamura K; Park KC; Hayakawa T
Anticancer Res; 1991; 11(6):2079-84. PubMed ID: 1776843
[TBL] [Abstract][Full Text] [Related]
25. The effect of peroxisome proliferator-activated receptor-gamma ligand on urological cancer cells.
Yoshimura R; Matsuyama M; Hase T; Tsuchida K; Kuratsukuri K; Kawahito Y; Sano H; Segawa Y; Nakatani T
Int J Mol Med; 2003 Dec; 12(6):861-5. PubMed ID: 14612958
[TBL] [Abstract][Full Text] [Related]
26. Differential effects of PPARgamma agonists on the metabolic properties of gliomas and astrocytes.
Spagnolo A; Grant EN; Glick R; Lichtor T; Feinstein DL
Neurosci Lett; 2007 Apr; 417(1):72-7. PubMed ID: 17324516
[TBL] [Abstract][Full Text] [Related]
27. Antitumor and apoptosis promoting properties of atorvastatin, an inhibitor of HMG-CoA reductase, against Dalton's Lymphoma Ascites tumor in mice.
Ajith TA; Anu V; Riji T
J Exp Ther Oncol; 2008; 7(4):291-8. PubMed ID: 19227009
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of Ras farnesylation by lovastatin leads to downregulation of proliferation and migration in primary cultured human glioblastoma cells.
Bouterfa HL; Sattelmeyer V; Czub S; Vordermark D; Roosen K; Tonn JC
Anticancer Res; 2000; 20(4):2761-71. PubMed ID: 10953355
[TBL] [Abstract][Full Text] [Related]
29. Fluvastatin and cisplatin demonstrate synergistic cytotoxicity in epithelial ovarian cancer cells.
Taylor-Harding B; Orsulic S; Karlan BY; Li AJ
Gynecol Oncol; 2010 Dec; 119(3):549-56. PubMed ID: 20837358
[TBL] [Abstract][Full Text] [Related]
30. The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells.
Yan KH; Yao CJ; Chang HY; Lai GM; Cheng AL; Chuang SE
Mol Carcinog; 2010 Mar; 49(3):235-46. PubMed ID: 19908241
[TBL] [Abstract][Full Text] [Related]
31. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
Wu JS; Lin TN; Wu KK
J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
[TBL] [Abstract][Full Text] [Related]
32. Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.
Weng JR; Chen CY; Pinzone JJ; Ringel MD; Chen CS
Endocr Relat Cancer; 2006 Jun; 13(2):401-13. PubMed ID: 16728570
[TBL] [Abstract][Full Text] [Related]
33. Effects of PPAR gamma agonists on cardiovascular function in obese, non-diabetic patients.
Panunti B; Fonseca V
Vascul Pharmacol; 2006 Jul; 45(1):29-35. PubMed ID: 16777491
[TBL] [Abstract][Full Text] [Related]
34. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells.
Hui AM; Zhang W; Chen W; Xi D; Purow B; Friedman GC; Fine HA
Cancer Res; 2004 Dec; 64(24):9115-23. PubMed ID: 15604281
[TBL] [Abstract][Full Text] [Related]
35. A novel PPAR alpha/gamma dual agonist inhibits cell growth and induces apoptosis in human glioblastoma T98G cells.
Liu DC; Zang CB; Liu HY; Possinger K; Fan SG; Elstner E
Acta Pharmacol Sin; 2004 Oct; 25(10):1312-9. PubMed ID: 15456533
[TBL] [Abstract][Full Text] [Related]
36. Ligands for the peroxisome proliferator-activated receptor-gamma have inhibitory effects on growth of human neuroblastoma cells in vitro.
Valentiner U; Carlsson M; Erttmann R; Hildebrandt H; Schumacher U
Toxicology; 2005 Sep; 213(1-2):157-68. PubMed ID: 16009482
[TBL] [Abstract][Full Text] [Related]
37. Effects of simvastatin, acetylsalicylic acid, and rosiglitazone on proliferation of normal and cancerous prostate epithelial cells at therapeutic concentrations.
Murtola TJ; Pennanen P; Syvälä H; Bläuer M; Ylikomi T; Tammela TL
Prostate; 2009 Jun; 69(9):1017-23. PubMed ID: 19301305
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
Liu JJ; Liu PQ; Lin DJ; Xiao RZ; Huang M; Li XD; He Y; Huang RW
Ann Hematol; 2007 Mar; 86(3):173-83. PubMed ID: 17089125
[TBL] [Abstract][Full Text] [Related]
39. Anticancer efficacy of simvastatin on prostate cancer cells and tumor xenografts is associated with inhibition of Akt and reduced prostate-specific antigen expression.
Kochuparambil ST; Al-Husein B; Goc A; Soliman S; Somanath PR
J Pharmacol Exp Ther; 2011 Feb; 336(2):496-505. PubMed ID: 21059805
[TBL] [Abstract][Full Text] [Related]
40. Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone--induced apoptosis in leukemia k562 cells and its mechanisms of action.
Liu JJ; Hu T; Wu XY; Wang CZ; Xu Y; Zhang Y; Xiao RZ; Lin DJ; Huang RW; Liu Q
Int J Toxicol; 2009; 28(2):123-31. PubMed ID: 19482836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]